Internal mammary artery graft function is not affected in hypertensive patients on therapy

Cardiovasc Surg. 1997 Aug;5(4):367-75. doi: 10.1016/s0967-2109(97)00055-0.

Abstract

Results are presented which assess the reactivity of isolated human internal mammary artery fragments from non-hypertensive and treated hypertensive patients in vitro. Material from three patient groups was examined: group I, no hypertension; group II, arterial hypertension treated with ACE inhibitors; and group III, arterial hypertension treated with nifedipine. Responses to KCl, norepinephrine and acetylcholine, as well as the influence of N(G)-monomethyl-L-arginine (L-NMMA) on the effects of norepinephrine were tested. Response to KCl was highest in group III, while the contractile reactivity to norepinephrine was depressed in group II. Relaxation after acetylcholine was enhanced in groups II and III. Incubation of vessel fragments with L-NMMA sensitized the tissue to norepinephrine in the order of potency group II>group III>group I. Internal mammary artery function as the graft, and particularly in terms of endothelial function, is not adversely affected in arterial hypertension, although proper antihypertensive treatment may be essential.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Captopril / pharmacology
  • Captopril / therapeutic use
  • Enalapril / pharmacology
  • Enalapril / therapeutic use
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / physiopathology*
  • Female
  • Humans
  • Hypertension / drug therapy
  • Hypertension / physiopathology*
  • In Vitro Techniques
  • Male
  • Mammary Arteries / drug effects
  • Mammary Arteries / physiopathology*
  • Middle Aged
  • Nitric Oxide / physiology
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Nitric Oxide
  • Enalapril
  • Captopril